Valuation: Edwards Lifesciences Corporation

Market Cap 53.05B 45.92B 42.92B 39.23B 73.93B 5,059B 75.08B 503B 198B 2,531B 199B 195B 8,430B P/E 2026 *
36.4x
P/E 2027 * 27.9x
Enterprise Value 49.55B 42.9B 40.09B 36.64B 69.05B 4,726B 70.13B 470B 184B 2,364B 186B 182B 7,874B EV / Sales 2026 *
7.33x
EV / Sales 2027 * 6.47x
Free-Float
86.97%
Yield 2026 *
-
Yield 2027 * -
1 day+0.98%
1 week+4.31%
Current month+8.59%
1 month+1.82%
3 months+21.12%
6 months+17.82%
Current year+9.64%
1 week 87.94
Extreme 87.945
93.81
1 month 81.16
Extreme 81.155
93.81
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap.
7/30/26 Sell

Executive/Senior Manager

-146 0.0000%
7/28/26 Fiscal year

Executive/Senior Manager

28,884 0.0050%
7/27/26 Don

Chief Executive Officer

-3,561 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%+4.31%+19.58%+17.70% 53.05B
-0.10%+5.92%+29.36%+10.00% 222B
-1.46%+6.01%+3.36%-19.16% 147B
+1.17%+8.54%-15.28%+31.28% 139B
+0.94%+4.14%-50.25%+0.18% 73.13B
+0.69%+1.23%-13.97%-16.34% 50.36B
+0.37%+7.13%+30.67%+17.55% 42B
-0.07%+3.92%+47.38%+41.13% 40.43B
-0.84%+3.50%-0.38%+1.58% 32.95B
+0.46%-1.21%-22.47%+22.83% 31.74B
Average +0.20%+217.82%+2.80%+10.67% 83.15B
Weighted average by Cap. +0.07%+304.83%+4.83%+8.48%

Financials

2026 *2027 *
Net sales 6.76B 5.85B 5.47B 5B 9.42B 645B 9.57B 64.14B 25.17B 323B 25.38B 24.83B 1,074B 7.43B 6.43B 6.01B 5.49B 10.35B 709B 10.52B 70.49B 27.66B 354B 27.9B 27.29B 1,181B
Net income 1.44B 1.24B 1.16B 1.06B 2B 137B 2.03B 13.62B 5.34B 68.48B 5.39B 5.27B 228B 1.9B 1.64B 1.53B 1.4B 2.64B 181B 2.68B 17.98B 7.06B 90.42B 7.12B 6.96B 301B
Net Debt -3.5B -3.03B -2.83B -2.59B -4.87B -333B -4.95B -33.17B -13.02B -167B -13.13B -12.84B -556B -5.01B -4.34B -4.05B -3.7B -6.98B -478B -7.09B -47.53B -18.65B -239B -18.81B -18.4B -796B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-08-11 US$93.18 +1.24% 1,145,152
26-08-10 US$92.03 +2.57% 4,443,994
26-08-07 US$89.72 +0.45% 2,442,024
26-08-06 US$89.32 +0.39% 2,655,569
26-08-05 US$88.97 -0.70% 3,665,538
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
92.03USD
Average target price
100.96USD
Spread / Average Target
+9.71%

Quarterly revenue - Rate of surprise